bcl-2 Transgene Expression Inhibits Apoptosis in the Germinal Center and Reveals Differences in the Selection of Memory B Cells and Bone Marrow Antibody-Forming Cells by Smith, Kenneth G.C. et al.
 
475
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/02/475/10 $5.00
Volume 191, Number 3, February 7, 2000 475–484
http://www.jem.org
 
bcl
 
-2 Transgene Expression Inhibits Apoptosis in the 
Germinal Center and Reveals Differences in the Selection of 
Memory B Cells and Bone Marrow Antibody-forming Cells
 
By Kenneth G.C. Smith,
 
‡
 
 Amanda Light,
 
*
 
 Lorraine A. O’Reilly,
 
*
 
 
Soon-Meng Ang,
 
*
 
 Andreas Strasser,
 
*
 
 and David Tarlinton
 
*
 
From 
 
*
 
The Walter and Eliza Hall Institute of Medical Research, Post Ofﬁce Royal Melbourne 
Hospital, Victoria 3050, Australia; and the 
 
‡
 
Cambridge Institute for Medical Research and the 
Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge
CB2 2QQ, United Kingdom
 
Abstract
 
Immunization with T cell–dependent antigens generates long-lived memory B cells and anti-
body-forming cells (AFCs). Both populations originate in germinal centers and, predomi-
nantly, produce antibodies with high affinity for antigen. The means by which germinal center
B cells are recruited into these populations remains unclear. We have examined affinity matu-
ration of antigen-specific B cells in mice expressing the cell death inhibitor 
 
bcl
 
-2 as a transgene.
Such mice had reduced apoptosis in germinal centers and an excessive number of memory B
cells with a low frequency of V gene somatic mutation, including those mutations encoding
amino acid exchanges known to enhance affinity. Despite the frequency of AFCs being in-
creased in 
 
bcl
 
-2–transgenic mice, the fraction secreting high-affinity antibody in the bone mar-
row at day 42 remained unchanged compared with controls. The inability of BCL-2 to alter
selection of bone marrow AFCs is consistent with these cells being selected within the germinal
center on the basis of their affinity being above some threshold rather than their survival being
due to a selective competition for an antigen-based signal. Continuous competition for antigen
does, however, explain formation of the memory compartment.
Key words: afﬁnity maturation • B cell • immunologic memory • plasma cell • somatic 
mutation
 
Introduction
 
During primary T cell–dependent immune responses, so-
matic mutation of Ig V region genes in germinal center B
cells generates variants expressing Ig with altered affinity for
antigen (1–3). Variants with improved affinity are posi-
tively selected so as to eventually comprise the majority of
the antigen-specific memory and antibody-forming cell
(AFC)
 
1
 
 B cell populations (4–7). The increasing frequency
of high-affinity B cells within these two populations is re-
ferred to as affinity maturation, a phenomenon originally
observed in the improvement in the average affinity of se-
rum antibodies (8). Although both memory B cells (2, 3)
and high-affinity AFCs located in the bone marrow (5, 6,
9) originate in the germinal center, the mechanism under-
lying the recruitment and maintenance of high-affinity ger-
minal center variants into these populations remains ob-
scure. Although it is generally regarded that memory B
cells require antigen for their continued survival (10), the
means by which bone marrow AFCs are selected and
maintained is less clear. A number of reports indicate that
once in the bone marrow, these AFCs are unresponsive to
antigen (9, 11, 12), arguing against antigen-dependent se-
lection in the bone marrow. This is consistent with the
downregulation of surface Ig on AFCs as they mature (5).
Takahashi and colleagues have proposed that, after the cells
leave the germinal center, selection for high-affinity bone
marrow AFCs continues in an antigen-dependent manner
(6, 13). If selection of memory B cells and bone marrow
AFCs utilizes similar criteria, it would follow that circum-
stances that alter selection of one cell type would affect the
other in the same manner. Differences in outcome, how-
ever, would indicate differences in selection criteria.
In this study, we have assessed the relative contribution of
cell survival mechanisms regulated by BCL-2 in the affinity
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maturation of antigen-specific memory B cell and AFC com-
partments. This was done by analysis of the immune response
in 
 
bcl
 
-2–transgenic mice in which, to a large degree, B cell
survival is independent of B cell antigen receptor (BCR)-
mediated stimuli (14–16). A previous analysis of the immune
response of these transgenic mice revealed an amplification
of both the antigen-specific germinal center/memory and
splenic AFC compartments (5), although affinity maturation
among the memory and bone marrow AFC compartments
was not measured. Although other groups have examined as-
pects of immunity in 
 
bcl
 
-2–transgenic mice (17, 18), the ef-
fects of blocking cell death in this way on affinity maturation
in the memory and AFC compartments has yet to be assessed.
Our results lead us to conclude that constitutive expres-
sion of the 
 
bcl
 
-2 cell survival gene distorts selection of the
memory B cell compartment while leaving the proportion
of high-affinity cells in the bone marrow AFC compartment
essentially unchanged. B cells with no affinity-enhancing
V
 
H
 
 gene somatic mutations persist in abnormally large num-
bers in the germinal center/memory B cell pathway of the
transgenic mice. Similarly, low-affinity AFCs persist in the
spleens of these mice. The preferential appearance of high-
affinity AFCs in the bone marrow, however, is not altered
despite an overall increase in the number of AFCs in both
the spleen and bone marrow. The ability of a 
 
bcl
 
-2 transgene
to alter the composition of the memory population but not
that of the bone marrow AFCs implies that fundamental dif-
ferences exist in the manner in which germinal center B
cells are selected and/or maintained in these compartments.
The basis of this difference is discussed.
 
Materials and Methods
 
Mice and Immunization.
 
Hemizygous transgenic mice of the
E
 
m
 
-
 
bcl
 
-2-36 strain (19), backcrossed with inbred C57BL/6 mice
for more than 15 generations, were provided by Drs. A.W. Har-
ris and S. Cory (The Walter and Eliza Hall Institute). Transgene-
bearing mice were identified as described (19). Nontransgenic lit-
termates were used as controls throughout. In most experiments,
mice were immunized by intraperitoneal injection of 100 
 
m
 
g of
alum-precipitated NP ([4-hydroxy-3-nitrophenyl]acetyl) conju-
gated to keyhole limpet hemocyanin (KLH) (NP/KLH conjuga-
tion ratio 17:1), prepared as described previously (20). For the
bromodeoxyuridine (BrdU) incorporation experiments, mice were
immunized subcutaneously at the base of the tail with 100 
 
m
 
g of
alum-precipitated NP
 
17
 
–KLH.
 
Immunofluorescent Staining, Flow Cytometric Analysis, and Cell
Sorting.
 
NP-specific memory B cells, defined as IgM
 
2
 
IgD
 
2
 
IgG1
 
1
 
CD38
 
1
 
 and NP binding, were resolved from other spleno-
cytes as previously described (21). The so-called “dump” channel
comprised biotin conjugates of the rat mAbs 281.2 (antisynde-
can), 331.12 (anti-IgM), and 11-26C (anti-IgD), all revealed with
streptavidin–PE (Caltag Labs.), plus propidium iodide to exclude
AFCs, naive B cells, and dead cells, respectively, from the analy-
sis. Antigen-specific B cells were identified by simultaneously
binding NP coupled to allophycocyanin and Texas Red–conju-
gated goat anti–mouse IgG1 (Southern Biotechnology Associ-
ates). CD38 expression levels, used to resolve NP-specific germi-
nal center (CD38
 
2
 
) and memory (CD38
 
1
 
) B cells (21), were
determined using FITC-conjugated NIMR5/18 (a gift from Dr.
 
M. Howard, DNAX Research Institute, Palo Alto, CA). Cells
were sorted with a dual laser FACStar
 
PLUS™
 
 (Becton Dickinson)
and an associated automated cell deposition unit (ACDU).
 
Cell Culture.
 
Cells were sorted into flat-bottomed 96-well
plates using the ACDU and cultured in 200 
 
m
 
l of RPMI culture me-
dium supplemented with 50 
 
m
 
M 2-ME, 10% FCS, IL-4, IL-5, and
an optimal concentration of CD40 ligand (CD40L) expressed from a
baculovirus construct (a gift from Dr.
 
 
 
P.
 
 
 
Hodgkin, Centenary Insti-
tute, Sydney, Australia). After 7 d, culture supernatants were assayed
for high-affinity and total anti-NP IgG1 as described below. Purified
NP-specific monoclonal IgG1 was used as a standard.
 
ELISA and ELISPOT Assays.
 
Total and high-affinity NP-
specific IgG1 was detected by ELISA using 96-well plates (Costar
Corp.) coated with NP
 
13
 
– and NP
 
2
 
–BSA, respectively, as de-
scribed (20). ELISPOT assays to enumerate AFCs were per-
formed by titrating bone marrow or spleen cells into replicate
wells of 96-well cellulose ester–based plates (Millipore Corp.)
coated with NP
 
13
 
– or NP
 
2
 
–BSA, followed by 16-h culture in
RPMI containing 50 
 
m
 
M 2-ME and 10% FCS. Plates were
washed, and bound NP-specific IgG1 was revealed with goat
anti–mouse IgG1 conjugated to horseradish peroxidase (Southern
Biotechnology Associates), visualized by the addition of 3-ami-
noethyl carbazole. Spots, each representing a single AFC, were
counted using a dissecting microscope.
 
V
 
H
 
 Gene Sequence Analysis of NP-specific B Cells.
 
Sequences of
V
 
H
 
186.2 genes were obtained from single NP-specific memory B
cells as described (5). Two rounds of PCR were performed on
cDNA derived from single B cells using nested primers specific
for C
 
g
 
1 (22), together with a single proximal 5
 
9
 
 primer for the
J558 V
 
H
 
 gene family (23). Products with bands of the expected
size were purified and sequenced, with V
 
H
 
186.2-containing se-
quences positively identified at this stage. The efficiency of each
step in this procedure is shown in Table I. The improved effi-
ciency of cDNA synthesis from 
 
bcl
 
-2–transgenic single B cells (80 vs.
40%) is presumably due to the enhanced viability of these cells
during the ex vivo manipulations. The entire PCR product was
sequenced, and the region encoding amino acids 10–96 was
compared in detail with the germline V
 
H
 
186.2 sequence (24). No
clonal repeats were found, as assessed by comparison of comple-
mentarity determining region (CDR)3 sequences.
 
BrdU Incorporation and Detection.
 
To identify proliferating cells
within LN germinal centers, mice immunized 14 d previously
were injected with a single dose of BrdU (100 
 
m
 
g per gram body
weight; Sigma Chemical Co.) dissolved in 0.007 N NaOH in
normal saline. After 6 h, the mice were killed, and LNs were
fixed in Bouin’s fluid and processed for paraffin embedding. Im-
munostaining was performed as described (25). In brief, sections
of LN were treated with xylene to remove paraffin and rehy-
drated in solutions with graded ethanol concentrations. Excessive
aldehydes in the fixed sections were quenched by incubation in
0.2 M glycine for 30 min. Sections were then treated for 30 min
with 0.3% hydrogen peroxide to block endogenous peroxidase,
followed by a 30-min incubation in 10% normal mouse serum to
block nonspecific binding sites. All antibody incubation steps
were for 30 min, followed by washings with PBS/1% BSA. To
make BrdU accessible to antibody, sections were pretreated with
1.4 N HCl for 2 h, followed by staining with rat anti-BrdU anti-
body (Sera-Lab Ltd.). Bound antibody was detected by the sec-
ondary reagent, biotinylated MAR 18.5 (mouse anti–rat Ig
 
k
 
).
The sections were then incubated for 30 min in avidin–peroxi-
dase complex (ABC Elite kit; Vector Labs., Inc.), followed by
detection with diaminobenzidene in 0.07% hydrogen peroxide as
the substrate. Sections were counterstained with hematoxylin, 
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dehydrated in alcohol and xylene, and mounted in DPX. All ger-
minal centers in two nonsequential sections from each of two
LNs from each control and 
 
bcl
 
-2–transgenic animal were scored
and the percentage of BrdU-containing cells within each germi-
nal center calculated. The average BrdU
 
1 
 
percentage from all in-
dividual germinal centers was then calculated for each mouse.
 
TUNEL Staining.
 
LN sections, initially treated as above,
were incubated with proteinase K (20 
 
m
 
g/ml) for 15 min and
then washed three times in PBS. Endogenous peroxidases were
blocked by incubating the sections with 0.3% hydrogen peroxide
in methanol for 5 min, followed by washing. Sections were then
incubated for 60 min in a humidified incubator with terminal
deoxynucleotidyltransferase (TdT; Promega Corp.) in the pres-
ence of biotinylated dUTP (Pharmacia). Incorporated biotiny-
lated dUTP was revealed with avidin–peroxidase complex (ABC
Elite kit; Vector Labs., Inc.), followed by detection with diami-
nobenzidene in 0.07% hydrogen peroxide as the substrate. Sec-
tions were counterstained with hematoxylin, dehydrated in alco-
hol and xylene, and mounted in DPX. TUNEL
 
1
 
 clusters within
germinal centers were scored from two nonsequential sections
from each of two LNs per mouse. Thus, a total of 12 sections
were analyzed for each genotype. Sections were photographed
using a Zeiss Axiaphot (Carl Zeiss, Inc.) with Kodak 64T film at
the degrees of magnification indicated.
 
Results
 
bcl-2 Promotes the Accumulation of Memory B Cells with Few
Ig V Gene Mutations.
 
To investigate the role of apoptotic
pathways blocked by BCL-2 in B cell selection in the ger-
minal center, we examined this process in mice expressing
a 
 
bcl
 
-2 transgene. We have shown previously that a 
 
bcl
 
-2
transgene expressed in the B cell lineage increases the cellu-
larity of the germinal center/memory compartment by 10-
to 20-fold (20). We sought to determine the nature of the
B cell expansion with respect to cell subset composition
and affinity-enhancing V
 
H
 
 gene mutations to gain insight
into selection in the germinal center. To evaluate which
population of B cells was expanded in the transgenic mice,
we determined CD38 expression on antigen-specific
IgG1
 
1
 
 B cells late in the primary immune response. Germi-
nal center B cells can be resolved from naive and memory B
cells by reduced levels of CD38 (21). Mice were immu-
nized by intraperitoneal injection of 100 
 
m
 
g of alum-pre-
cipitated NP–KLH, and 42 d later they were examined for
the frequency of isotype-switched NP-binding B cells. Ap-
proximately 50% of NP-binding IgG1
 
1
 
 B cells in the
spleens of control mice were CD38
 
1
 
, whereas the remain-
der retained the CD38
 
lo
 
 germinal center B cell phenotype.
More than 80% of NP
 
1
 
IgG1
 
1
 
 B cells in the 
 
bcl
 
-2–trans-
genic mice had the CD38
 
1
 
 memory phenotype (Fig. 1 A).
That the expanded CD38
 
1
 
 antigen-specific B cell popula-
tion in the spleens of 
 
bcl
 
-2–transgenic mice actually consti-
tuted the memory population and was not due to altered
CD38 regulation in the transgenic B cells was confirmed by
the following observations. First, these B cells bound low
Figure 1. Levels of CD38 on antigen-specific
IgG1 B cells at day 42 of the primary response.
(A) Spleens from mice immunized 42 d previ-
ously with 100 mg i.p. of NP–KLH were
stained with the indicated antibodies and analyzed
by flow cytometry. Viable cells having the phe-
notype IgM2IgD2 were electronically gated on
(rectangle) and examined for expression of IgG1
and the ability to bind the immunizing hapten
NP coupled to a fluorescent protein. Such dou-
ble-positive cells were gated on (rectangle), and
the level of CD38 was determined. This result
is depicted as the solid histogram in this figure.
Negative control staining was less than the fluo-
rescence level marked by the dashed vertical
line. The percentages of NP-binding IgG11 cells
expressing high levels of CD38 are indicated.
Cells used in this experiment were pooled from
three mice, and the data shown are represen-
tative of three experiments. (B) Germinal cen-
ter cells in bcl-2–transgenic mice downregulate
CD38. Mesenteric LN B cells were gated on by expression of CD45R. These cells were then examined for CD38 levels and
binding of the lectin peanut agglutinin; such B cells are boxed. 
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levels of peanut agglutinin and did not have the light scat-
ter characteristics of blast cells (data not shown). Second,
germinal center B cells within the mesenteric LNs of 
 
bcl
 
-
2–transgenic mice reduced CD38 expression to the same
extent as control mice (Fig. 1 B), indicating that CD38 ex-
pression is regulated appropriately in these mice.
We next compared the distribution of V
 
H
 
 gene somatic
mutations in purified NP-binding B cells from transgenic
 
and control mice. To ensure that the same B cell popula-
tions were compared, we focused on the antigen-specific
CD38
 
1
 
 subset. Single IgG1
 
1
 
 NP-specific CD38
 
1
 
 B cells were
sorted from the spleens of 
 
bcl
 
-2–transgenic and control
mice immunized 42 d previously. IgG
 
1
 
 rearrangements in-
volving the V
 
H
 
186.2 gene segment were amplified by PCR
from cDNA templates and sequenced. Analysis of these se-
quences from 
 
bcl
 
-2 mice revealed a number of differences
in the pattern of somatic mutation seen in the equivalent
control B cell population (Table I and Fig. 2 A). First, 25%
of the V
 
H
 
186.2 sequences from 
 
bcl
 
-2–transgenic cells con-
tained zero mutations, compared with 4% in controls. Sec-
ond, 36% of V
 
H
 
186.2 gene sequences from 
 
bcl
 
-2–transgenic
mice contained either one or two mutations and lacked the
affinity-enhancing tryptophan
 
®
 
leucine exchange at amino
acid 33. The equivalent group comprised 16% of control
sequences. Thus, some 60% of memory phenotype B cells
in the 
 
bcl
 
-2–transgenic mice showed no evidence of affinity
maturation of their V
 
H
 
 gene sequences, compared with
only 20% in controls. The affinity-enhancing exchange at
V
 
H
 
 position 33 was present in 13% of 
 
bcl
 
-2–transgenic
memory B cells, compared with 64% in control mice (Ta-
ble I and Fig. 2), which indicated that BCL-2 did not pre-
vent the appearance of high-affinity cells. The cumulative
distribution of somatic mutations in the V
 
H
 
 gene sequences
is depicted in Fig. 2 B. It should also be noted that the pro-
portion of recovered PCR products using the V
 
H
 
186.2
 
Table I.
 
Summary of V
 
H
 
186.2 Sequences from NP-specific IgG1
 
1
 
 
B Cells at Day 42 after Immunization
 
Control CD38
 
1
 
bcl
 
-2 CD38
 
1
 
Single cells 74 38
PCR
 
1
 
31 32
V
 
H
 
186.2
 
1
 
26 24
R/S ratio
CDR1
 
1
 
2 4.0 2.9
FW1
 
2
 
3 2.7 1.8
Position 33 W
 
®
 
L 62% 13%
Mutation average 4.6 2.7
Range 0–14 0–12
R/S ratio, ratio of replacement to silent mutations.
Figure 2. Reduced frequency of
VH gene somatic mutations in NP-
specific memory B cells from bcl-2–
transgenic mice. The frequency of
mutations in VH186.2 genes from
single, antigen-specific CD381IgG11
B cells was determined by nucleotide
sequencing. Single cells were sorted
from a pooled spleen preparation
from each mouse strain using the cri-
teria depicted in Fig. 1. All recovered
sequences showed unique CDR3
junctions, indicating clonality. (B)
Cumulative distribution of somatic
mutations in control and bcl-2 NP-
specific B cells. In both components
of the figure, the number of se-
quences containing mutations giving
rise to a tryptophan®leucine exchange at amino acid 33 (numbered according to reference 24) is depicted by the hatched segment of each column. Details
of the sequences are summarized in Table I. These sequence data are available from EMBL/GenBank/DDBJ under accession no. AF210258-AF210307.479 Smith et al.
gene segment was the same in antigen-specific B cells from
both types of mice. That is, there was no bias toward re-
lated VH genes in the bcl-2–transgenic memory B cells. Fi-
nally, when VH genes were sequenced from populations of
IgG11 antigen-specific B cells irrespective of their CD38
levels (i.e., all B2201IgG11 NP-binding cells) from both
bcl-2 and control mice, the observed pattern of mutations
was very similar to that observed when CD38 was used as a
marker (not shown).
From these results, it should follow that NP-specific Ig
produced by the memory B cell population of bcl-2–trans-
genic mice should correlate with a lower degree of affinity
maturation than Ig produced by the equivalent population
from control mice. To determine whether this was the case,
IgM2IgD2CD381IgG11 NP-binding B cells were sorted
from spleens of bcl-2–transgenic and control mice at day
42 after immunization and stimulated in vitro with CD40L
plus cytokines. The fraction of total NP-specific IgG1 able
to bind to NP2-conjugated plate coats from bcl-2–trans-
genic mice was 30%, compared with 100% in control cul-
tures. This confirms a lower representation of high-affinity
B cells in the bcl-2 memory B cell population. Collectively,
these data demonstrate the persistence of excessive numbers
of low-affinity B cells in the memory populations of bcl-2–
transgenic mice.
Transgenic expression of bcl-2 therefore results in the
persistence of cells with a memory phenotype and a pattern
of VH gene mutations suggesting low affinity, an observa-
tion confirmed by measurement of the affinity of antibody
produced by these same cells after sorting and culture in
vitro. These results indicate that constitutive expression of
BCL-2 allows for and may even enhance the differentiation
of germinal center cells into memory cells, despite their be-
ing of low affinity.
bcl-2 Inhibits Apoptosis and Proliferation in Germinal Centers
to Varying Degrees. BCL-2, defined as an inhibitor of apop-
tosis (26), is also able to delay entry of mitogen-stimulated
lymphocytes into the cell cycle (27–29). To better define
the basis of the effect of constitutive bcl-2 expression on se-
lection of antigen-specific B cells, we sought to quantify
the extent of apoptosis and proliferation in the germinal
centers of bcl-2–transgenic mice. For these experiments, mice
were immunized at the base of the tail, and 14 d later the
paraaortic LNs were taken, fixed in paraformaldehyde, and
sectioned. Paraaortic LNs were chosen because without
deliberate immunization, this tissue contained no germinal
centers and we could therefore be certain that all of the
germinal centers that developed had developed in a syn-
chronized manner. Sections from immunized and unim-
munized transgenic and control animals were stained using
the TUNEL (TdT-mediated dUTP-biotin nick-end label-
ing) technique to reveal the frequency of apoptotic cells
(Fig. 3). The results show that BCL-2 reduced apoptosis by
a factor of z10-fold (Table II). This implies that the major
form of cell death in germinal centers is due to apoptotic
pathways that can be blocked by BCL-2 and that BCL-
2–insensitive pathways of apoptosis, such as those activated
by death receptors, play only a minor role (30, 31).
The frequency of proliferating cells in LN germinal cen-
ters of bcl-2–transgenic and control mice was determined
by scoring the number of cells per germinal center that had
incorporated BrdU during a 6-h pulse. Histological sec-
tions were first scored for the frequency and size of germi-
nal centers, and no significant difference was observed be-
tween bcl-2–transgenic mice and controls (Table III). The
similarity in germinal center size and frequency in the two
strains implies that the additional antigen-specific B cells
that accumulate during the immune response in the bcl-
2–transgenic mice reside in a postgerminal center compart-
ment. This is consistent with the increased frequency of B
cells with a memory phenotype defined above (Fig. 1). The
fraction of cells synthesizing DNA during the 6-h pulse dif-
fered somewhat between the two groups, with transgenic
mice showing a decrease of z25% (Table III). As the size
Figure 3. The frequency of
apoptotic cells in germinal cen-
ters is reduced in bcl-2–trans-
genic mice. 2 wk after immuni-
zation, LNs were sectioned and
stained for the presence of apop-
totic cells using the TUNEL
technique. An example of one
such experiment using LNs from
immunized and unimmunized
control and bcl-2–transgenic
mice is shown. Arrows indicate
the location of germinal centers.
No germinal centers were ob-
served in the LNs of unimmu-
nized mice. Magnification is 100,
and one representative section is
shown. Quantification of this
data is presented in Table III.480 B Cell Selection in the Antibody Response
distribution of germinal centers in the two strains was the
same (Table III), the decrease in the proportion of BrdU-
labeled germinal center cells in the bcl-2–transgenic mice is
equivalent to a reduced number of proliferating cells. Thus,
constitutive bcl-2 expression does not affect germinal center
formation but does reduce both apoptosis and proliferation
within the germinal center, although the effect on the
former is much greater.
High-Affinity AFCs Are Selectively Recruited into the Bone
Marrow of bcl-2–transgenic Mice. Having observed an enhanced
preservation of low-affinity B cells within the memory
compartment of bcl-2–transgenic mice, we next examined
whether the AFC compartments in the spleen and bone
marrow were similarly affected. We measured the fre-
quency of high-affinity NP-specific IgG1 AFCs in spleens
and bone marrow of bcl-2–transgenic and control animals
(Table IV). At day 42 after immunization, the average fre-
quency of NP-specific IgG1 AFCs in the spleens of control
mice was 1.5 per 105 splenocytes, of which 90% were high
affinity, as determined by binding to the low conjugation
plate coat, NP2–BSA. The frequency of antigen-specific
IgG1 AFCs in the bone marrow of control animals at day
42 was 5 per 105 cells, of which 80% were high affinity,
a proportion not significantly different from that in the
spleens of the same animals (Table IV). Thus, in control
mice at this time after primary immunization, the vast
majority of antigen-specific AFCs secreted high-affinity an-
tibody, irrespective of their location. The situation in bcl-
2–transgenic animals differed in two respects: first, the fre-
quency of NP-specific IgG1 AFC was higher, and second,
the degree of affinity maturation differed between the tis-
sues examined (Table IV). The frequency of NP-specific
IgG1 AFCs in the spleens of bcl-2–transgenic mice was
z50-fold higher than in controls—corresponding to a 150-
fold increase in absolute numbers—but only 30% of these
AFC secreted high-affinity antibody (Table IV). This result
confirms the preservation of splenic AFCs in bcl-2–trans-
genic mice (19, 20) and demonstrates that most of these
cells secrete low-affinity Ig. Although the frequency of NP-
specific IgG1 AFCs in the bone marrow of bcl-2–transgenic
mice was approximately threefold higher than in controls,
the proportion of AFCs secreting high-affinity antibody
was close to normal at 70%. Importantly, the degree of
affinity maturation amongst the bone marrow AFCs of bcl-
2–transgenic mice differed significantly from that in the
spleen of these mice (Table IV). That high-affinity cells ac-
cumulate normally in the bone marrow AFC compartment
of  bcl-2–transgenic mice but fail to do so in either the
memory or splenic AFC compartments demonstrates a sig-
nificant difference in the selective processes operating to es-
tablish and/or maintain these populations of antigen-spe-
cific B cells.
Discussion
It is widely accepted that both the memory B cell and
high-affinity AFC populations are recruited in the germinal
center on the basis of their affinity for antigen (2, 3, 5, 6).
Although little is known regarding the molecular signals
underpinning germinal center activity, a model to explain
affinity maturation in the germinal center (2, 3, 32, 33)
may be summarized as follows. Somatic hypermutation of
Ig V genes randomizes the affinity for antigen of B cells
within germinal centers. Some variants will have their af-
finity increased, some left unchanged, and others decreased.
As germinal center B cells require an antigen-dependent
Table II. Apoptosis in the Germinal Centers of bcl-2–transgenic 
and Control Mice
Mouse
TUNEL1 clusters per germinal center
in immunized mice*
bcl-2 Control
1 0.8 6 1.7 8.2 6 6.2
2 0.8 6 1.0 8.1 6 3.8
3 2.7 6 2.1 9.7 6 3.7
Mean 1.4 8.7
*All germinal centers on two sections from each of two LNs from each
immunized mouse were scored. The average number of TUNEL1
clusters for each mouse was calculated. Germinal centers were not de-
tected in unimmunized mice.
Table III. Proliferation in the Germinal Centers of bcl-2–transgenic 
and Control Mice
Mouse
Percent
BrdU1 cells
per GC*
GC size‡
(cells per germinal center)
Total
Small
(1–99)
Medium
(100–299)
Large
(.300)
Control 1 41.6 6 10.6 0 16 2 18
2 43.0 6 13.6 1 21 6 28
3 35.9 6 14.8 4 12 1 15
Mean§ 40.8 1.7 16.0 3.0 —
bcl-2 1 27.3 6 11.3 3 17 3 23
2 19.2 6 9.3 0 11 5 16
3 31.1 6 13.7 3 18 11 32
Mean 27.2 2.0 15.3 6.3 —
GC, germinal center.
*Immunized mice were injected with BrdU, and sections were pre-
pared from two paraaortic LNs per mouse. Nodes from three unimmu-
nized mice of each strain showed no germinal centers. The proportion
of BrdU1 cells in each germinal center was determined and averaged
for each mouse.
‡Germinal center size was determined by cell count. All germinal cen-
ters within a given section were scored for the number of cells and then
allocated into the catagories listed. Two discontinuous sections from
each of two nodes from each mouse were scored.
§The mean percentage of BrdU1 cells averaged for all germinal centers
over all sections scored.481 Smith et al.
signal for their continued survival and participation in the
processes of affinity maturation, those with improved affin-
ity will have a competitive advantage in accessing antigen,
localized in the germinal center as immune complexes on
follicular dendritic cells. Such high-affinity B cells will
therefore preferentially survive and thus will come to dom-
inate the germinal center and, eventually, the memory
population. Germinal center B cells that fail to receive anti-
gen-dependent survival signals will undergo apoptosis, re-
inforcing the ascendancy of the high-affinity variants. In
such a model, preventing the death of low-affinity variants
should distort the process of affinity maturation. This model
of germinal center activity in the generation of B cell
memory is well supported by data from our current analysis
of bcl-2–transgenic mice. By blocking apoptosis in the ger-
minal center, a population of low-affinity B cells has been
preserved inappropriately, and these cells have assumed the
phenotype of memory B cells (Fig. 1). This result implies
that cell survival is a key determinant for entry into the
memory B cell compartment. Thus, a constitutive cell sur-
vival signal has uncoupled affinity maturation in the germi-
nal center from entry into the memory B cell compart-
ment. This provides the first direct evidence that formation
of a normally selected memory B cell compartment re-
quires apoptosis in the germinal center.
A model of survival-dependent differentiation, however,
does not explain the formation of the high-affinity bone
marrow AFC compartment. Transgenic bcl-2 clearly pro-
moted the survival of AFCs, as demonstrated by the 50-
fold increase in antigen-specific IgG1 AFCs in the spleen
and threefold increase in bone marrow AFCs (Table IV).
Recruitment and persistence of AFCs in the bone marrow,
however, was not random, as the fraction of such cells se-
creting high-affinity antibody remained the same as in con-
trols (Table IV). That is, germinal center–derived cells were
recruited into the bone marrow AFC compartment on the
basis of affinity and not solely on their potential to survive.
Thus, the ability of BCL-2 to distort affinity maturation of
memory B cells but not bone marrow AFCs reveals a fun-
damental difference in the means by which these popula-
tions are formed (or possibly maintained) from germinal
center precursors.
One explanation of how transgenic bcl-2 alters the com-
position of the memory B cell population but not that of
bone marrow AFCs is that the differentiation of germinal
center B cells is determined by the strength of the BCR in-
teraction with antigen. B cells that bind antigen avidly will
have a greater degree of receptor occupancy and cross-link
more of their surface Ig than B cells with low-affinity Ig.
This strength of signal could then be translated into com-
mitment to differentiate into an AFC at the high end of the
spectrum, survival in the germinal center at a central level,
or apoptosis at the low end of the spectrum. Thus, differ-
entiation into an AFC requires a particular threshold of sig-
nal strength to be reached, a signal that cannot be provided
by BCL-2. Current data do not allow determination of
where or over what time frame this BCR signal would be
delivered, although recent data suggest a period of postger-
minal center selection in bone marrow AFC formation (6).
Indeed, an extended period of selection may distinguish the
developmental pathway of bone marrow AFCs from that
Figure 4. Selection in the germinal center during the development of
memory and AFCs in a primary immune response. A schematic represen-
tation of the forces acting to influence the outcome of the germinal cen-
ter reaction during the primary immune response. Indicted are the fact
that (a) high-affinity cells selectively become AFCs; (b) low-affinity cells
apoptose, an event that can be blocked by BCL-2; and (c) intermediate
affinity cells remain in the germinal center. As the response progresses, the
affinity threshold for each differentiation pathway will increase as the cells
compete with antibody in serum. It is predicted that this reaches a level
where memory B cell production will be the favored outcome. This
change may well involve FcgRII.
Table IV. Frequency and Affinity of AFCs at Day 42 of the Primary Response
Anti-NP IgG1 AFCs per 105 Input Cells at Day 42
Spleen Bone marrow
NP2 NP13 Ratio NP2 NP13 Ratio P value*
Control‡ 1.3 6 1.1 1.4 6 0.9 0.9 6 0.04 7.9 6 6.6 10.2 6 9.3 0.8 6 0.03 0.46
bcl-2 18.0 6 9.0 64.8 6 33.0 0.3 6 0.01 21.3 6 12 31.0 6 17.0 0.7 6 0.01 ,0.001
P value ,0.001 0.43
*P values calculated with Student’s t test using the average of the NP2/NP13 ratio calculated for each mouse. 
‡Frequencies are the average 6 SD from five mice of each genotype. Results are representative of three experiments.482 B Cell Selection in the Antibody Response
of the splenic foci, which are very sensitive to bcl-2 (Table
IV). The proposed model of the germinal center (Fig. 4)
accounts for several aspects of germinal center activity: (a)
the early appearance of sparsely mutated, high-affinity
AFCs in the bone marrow (5) and their corresponding ab-
sence from the germinal center (34); (b) the particular abil-
ity of BCL-2 to rescue low-affinity B cells in the germinal
center; and (c) the continued improvement of AFC affinity
during the first weeks of the response (5, 6). This last ob-
servation would reflect the continued heightening of the
affinity threshold necessary to enter the AFC population
caused by germinal center–derived B cells having to com-
pete with increasing titers of high-affinity serum Ig. Such
competition would also require B cells within the germinal
center to improve their affinity for antigen to receive a sig-
nal of sufficient strength to ensure their survival. The affin-
ity of the memory B cell population would therefore be
improved but would lag behind that of the cells destined to
become bone marrow AFCs.
The concept of lymphocyte differentiation being influ-
enced by the degree of receptor occupancy has been pro-
posed to explain early stages of the B cell response to both
self- and foreign antigen (35, 36). Regulating differentia-
tion by the same mechanism in the germinal center would
obviate the need for unique signaling pathways for different
developmental stages. A prediction of this model is that
mutations that alter the threshold of BCR-mediated activa-
tion should have an inverse effect on affinity maturation.
Thus, mice with hyperresponsive B cells should show di-
minished affinity maturation, whereas those with hypore-
sponsive B cells should show more stringent selection. This
principle may, for example, underlie the poor survival in
germinal centers of B cells rendered hyporesponsive by ab-
lation of CD21 (37) and CD19 (38). A definitive answer
requires a more detailed analysis of affinity maturation in
these mice.
A fundamental question remaining to be answered is,
What changes occur to allow the germinal center output to
shift from AFC production to that of memory B cell pro-
duction? The memory B cell population is formed over a
longer period than the bone marrow AFC population (21,
39, 40), although analysis of V gene somatic mutation indi-
cates that the bulk of the memory population is generated
late in the response (4, 5, 41). As this corresponds to the
period of the response when titers of antibody are highest,
it may be that B cell Fc receptors are of prime importance.
Cross-linking FcgRIIb with the BCR inhibits B cell pro-
liferation (42) and differentiation into AFCs (43) and may
thus trigger germinal center B cells to assume a memory
phenotype. Interestingly, in the absence of FcgRII, anti-
body production is elevated in response to immunization
(44), consistent with FcgRII being involved in cessation of
AFC production.
Our analysis of the immune response of bcl-2–transgenic
mice is not the first to address the impact of apoptosis on
affinity maturation. Transgenic mice expressing in their B
cells the bcl-2 homologue bcl-xL have been similarly ana-
lyzed (13). Despite the similarity of mechanism by which
these two antiapoptotic genes block cell death (45), some
differences are evident in the results obtained. First, bcl-xL
mice show no increase in the frequency or longevity of
AFCs in either the spleen or bone marrow compared with
bcl-2 mice in which both of these compartments are ampli-
fied, raising the question of whether the bcl-xL transgene is
expressed in terminally differentiated B cells. Second, bcl-
xL mice show reduced affinity maturation of both serum Ig
and bone marrow AFCs (13), again unlike bcl-2 mice (Ta-
ble IV and reference 20). Third, there was an abnormal
persistence of B cells containing noncanonical VDJ gene
rearrangements in bcl-xL mice despite V186.2 rearrange-
ments being normally mutated and selected (13). That is,
the effect of the bcl-xL transgene appeared to be restricted
to B cells bearing non-VH186.2 rearrangements. The ef-
fects of the bcl-2 transgene reported here, on the other
hand, are distributed irrespective of VH gene content, as
there is no distortion of VH gene usage in any of the com-
partments examined (Table I). Thus, without knowing the
full extent of bcl-xL transgene expression, we must assume
that the differences in results obtained are due to the bcl-xL
transgene not being expressed in all B cell compartments.
This may also explain the variance observed between these
two strains in a model system of self-, anti-self B cell toler-
ance (46).
In summary, we have used bcl-2–transgenic mice to
demonstrate that apoptosis of low-affinity germinal center
B cells is necessary for the formation of a normally selected
memory B cell population. Moreover, this increase in ger-
minal center cell survival revealed marked differences in
the nature of selection of memory B cells and bone marrow
AFCs. Selection of the memory compartment was per-
turbed by constitutive bcl-2 expression in the germinal cen-
ter, consistent with a model of selection where competition
of B cells for an antigen-mediated survival signal is required
for entry to the memory compartment. In contrast, the
stringent selection of high-affinity bone marrow AFCs is
not influenced by the bcl-2 transgene, consistent with a se-
lective process requiring the germinal center B cell to ex-
ceed an “affinity threshold.”
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